메뉴 건너뛰기




Volumn 8, Issue 4, 2008, Pages 295-300

Future targets for immune therapy in colitis?

Author keywords

Chemokine; Colitis; Immune therapy; Inflammation; Regulatory T cells

Indexed keywords

AMINOSALICYLIC ACID; CHEMOKINE; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR3; CYTOKINE; CYTOKINE ANTIBODY; GAMMA INTERFERON INDUCIBLE PROTEIN 10 ANTIBODY; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 8; KINVET; MONOCLONAL ANTIBODY; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STAT3 PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR GATA 2; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

EID: 58249086494     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153008786848277     Document Type: Review
Times cited : (6)

References (69)
  • 10
  • 15


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.